Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of Surgical Oncology
|
August 7, 2019
Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
Danielle K DePalo, Rachel M Lee, Alexandra G Lopez-Aguiar, et al.
Annals of Diagnostic Pathology
|
September 11, 2014
Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer
Jane H Zhou, Daniel Rosen, Andreas Andreou, et al.
Frontiers in Oncology
|
January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Samantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
World Journal of Surgery
|
April 28, 2025
Predicting Severe Postoperative Complications after CRS-HIPEC: An Externally Validated Machine-Learning Tool
Amir Ashraf Ganjouei, Jane Wang, Christopher Yi, et al.
JAMA Surgery
|
November 2, 2018
Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors
Mohammad Y Zaidi, Alexandra G Lopez-Aguiar, Mary Dillhoff, et al.
Practical Radiation Oncology
|
February 9, 2025
Neoadjuvant SBRT plus Elective Nodal Irradiation with Concurrent Capecitabine for Patients with Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase 1 Trial
Mustafa M Basree, Jacob S Witt, Nataliya V Uboha, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 22, 2019
Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?
Angelena Crown, Vlad V Simianu, Hagen Kennecke, et al.
American Journal of Surgery
|
January 29, 2019
Gastric carcinoids: Does type of surgery or tumor affect survival?
Angelena Crown, Hagen Kennecke, Richard Kozarek, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer
Jacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
Annals of Surgical Oncology
|
November 1, 2022
Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium
Ifeanyichukwu Ogobuiro, Amber L Collier, Khadeja Khan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of Surgical Oncology
|
August 7, 2019
Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
Danielle K DePalo, Rachel M Lee, Alexandra G Lopez-Aguiar, et al.
Annals of Diagnostic Pathology
|
September 11, 2014
Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer
Jane H Zhou, Daniel Rosen, Andreas Andreou, et al.
Frontiers in Oncology
|
January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Samantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
World Journal of Surgery
|
April 28, 2025
Predicting Severe Postoperative Complications after CRS-HIPEC: An Externally Validated Machine-Learning Tool
Amir Ashraf Ganjouei, Jane Wang, Christopher Yi, et al.
JAMA Surgery
|
November 2, 2018
Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors
Mohammad Y Zaidi, Alexandra G Lopez-Aguiar, Mary Dillhoff, et al.
Practical Radiation Oncology
|
February 9, 2025
Neoadjuvant SBRT plus Elective Nodal Irradiation with Concurrent Capecitabine for Patients with Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase 1 Trial
Mustafa M Basree, Jacob S Witt, Nataliya V Uboha, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 22, 2019
Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?
Angelena Crown, Vlad V Simianu, Hagen Kennecke, et al.
American Journal of Surgery
|
January 29, 2019
Gastric carcinoids: Does type of surgery or tumor affect survival?
Angelena Crown, Hagen Kennecke, Richard Kozarek, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer
Jacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
Annals of Surgical Oncology
|
November 1, 2022
Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium
Ifeanyichukwu Ogobuiro, Amber L Collier, Khadeja Khan, et al.
Page
of 3